CLOs on the Move

JenaValve

www.jenavalve.com

 
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.jenavalve.com
  • 1000 N. West Street Suite 1200
    Wilmington, DE USA 19801
  • Phone: 302.295.4897

Executives

Name Title Contact Details

Similar Companies

Cbd Ophthalmic

Cbd Ophthalmic is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Distribution Solutions

Medical Distribution Solutions is a Lawrenceville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tactile Systems Technology Inc

Tactile Systems Technology Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

Joint Active Systems

Joint Active Systems is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.